Actively Recruiting
Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
Led by Fundació Sant Joan de Déu · Updated on 2024-05-29
120
Participants Needed
1
Research Sites
162 weeks
Total Duration
On this page
Sponsors
F
Fundació Sant Joan de Déu
Lead Sponsor
U
University Ramon Llull
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of this study is to investigate the efficacy, efficiency, and patient experience of a new intervention program on adolescents with high-complexity eating disorders (ED). A prospective group of adolescents with ED (N=60) will follow this treatment program including four different phases: 1) Inpatient treatment; 2) Family Treatment Apartment; 3) Home Treatment; 4) Recovery within the community. The investigators will use a retrospective, control group (N=60) that matched the prospective group in age, sex, ED diagnosis, and severe symptomatology. Primary variables regarding Body Mass Index (BMI), ED symptomatology, functionality, recovery (yes/no), type of outpatient services (low/mid/high intensity), number of readmissions, and patient experience will be assessed at discharge, and after 6 and 12 months. Secondary variables include anxiety, depression, readiness to recover, quality of life symptoms, caregiver skills, and functionality of the family
CONDITIONS
Official Title
Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient diagnosed with an Eating Disorder (according to the DSM-5) through a semi-structured interview (K-SADS PL-5)
- Aged between 12 and 17 years old
- Both patients and parents are willing to participate in the study and sign the informed consent to accept participation
- Patient with a poor response to treatment, defined as having one of the following two conditions:
- undergoing over a year of treatment, including partial and total hospitalization, without symptom stabilization, experiencing severe psychological distress, eating symptomatology, comorbidities, or family dysfunction during this period (clinical improvement of at least 50 on the CGAS functioning scale) OR
- undergoing more than three admissions without symptom stabilization (clinical improvement of at least 50 on the CGAS functioning scale)
- Aged between 12 and 17 years old (retrospective control group)
- Diagnosed with an Eating Disorder (according to the DSM-5) (retrospective control group)
- Received treatment in Sant Joan de Déu between 2012 and 2022 (retrospective control group)
- Patient with a poor response to treatment, defined as having one of the following two conditions:
- undergoing over a year of treatment, including partial or total hospitalization, without achieving stabilization of ED symptomatology (needing high-intensive treatment units i.e. not being able to follow individual treatment in external consultations) OR
- undergoing more than three admissions without symptom stabilization once referred to partial hospitalization in less than one year, including a similar psychological state and characteristics as the first condition (retrospective control group)
You will not qualify if you...
- Acute ED pathology and biological decompensation that require urgent pediatric attention or admission to an acute psychiatric ward (prospective group)
- Missingness of 20% or more of the required data (retrospective control group)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital Sant Joan de Déu
Barcelona, Spain, 08950
Actively Recruiting
Research Team
E
Eduardo Serrano-Troncoso, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here